Beneficient Reports $2.8 Million Net Loss for Quarter Ended September 30, 2025

Beneficient, a technology-enabled financial services company, reported a net loss of $2.8 million in revenues for the quarter ended September 30, 2025, compared to a net revenue of $8.6 million for the same period in 2024. The company's operating loss was $17.9 million, compared to an operating loss of $13.7 million in the prior year. This decline was primarily attributed to a decrease in investment income and an increase in interest expenses. Net loss attributable to Beneficient common shareholders was $3.6 million, or $0.37 per share, compared to a net income of $12.9 million, or $2.98 per share, in the prior year.

The company's financial statements reflect the consolidation of Customer ExAlt Trusts, which are variable interest entities. These trusts hold the collateral for ExAlt Loans, and transactions between Beneficient's operating subsidiaries and these trusts are eliminated in the consolidated presentation. As a result, the consolidated financial statements include the assets, liabilities, revenues, and expenses of both Beneficient and the Customer ExAlt Trusts, with a portion of the economic interests of the trusts attributed to noncontrolling interests. The company's primary tangible assets are investments held by the Customer ExAlt Trusts, and revenues are primarily derived from investment income and gains or losses on financial instruments held by these trusts.

Significant changes in operating expenses included a decrease in employee compensation and benefits, offset by an increase in interest expense. Professional services expenses also decreased, primarily due to lower legal fees. The company reported a loss contingency related to an arbitration award, which significantly impacted the net loss for the period. The company's liquidity remains a concern, with substantial doubt about its ability to continue as a going concern within one year.

Beneficient is actively working to address its liquidity challenges through various measures, including the issuance of additional debt or equity, monetization of investments held by the Customer ExAlt Trusts, and potential refinancing of existing borrowings. The company is also pursuing options to reduce corporate overhead and is evaluating its options with respect to the arbitration award. The company's ability to improve its financial performance and maintain its listing on the Nasdaq stock market is subject to various risks and uncertainties, including market conditions, regulatory factors, and legal proceedings. As of November 10, 2025, Beneficient had 110,758,536 shares of Class A common stock outstanding and 239,256 shares of Class B common stock outstanding.